Bohumila Brunova

Title: Bohumila Brunova: Innovator in Pharmaceutical Chemistry

Introduction

Bohumila Brunova is a notable inventor based in Prague, Czech Republic. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 4 patents. His work focuses on developing compounds with therapeutic properties, particularly in the areas of anti-arthritic and analgesic medications.

Latest Patents

One of his latest inventions is 5-[4-(4,6-dimethyl-2-pyrimidinylsulfamoyl)phenylazo]acetylsalicylic acid, also known as DISALAZINE. This compound is recognized for its anti-arthritic and immunomodulating properties. It is synthesized through the reaction of the diazonium salt of sulfadimidine with salicylic acid, followed by acetylation. Another significant patent involves an etheric derivative of 4(3H)-quinazolinone, specifically a fluorinated 3-[2-(4-biphenylyloxy)ethyl]-4(3H)-quinazolinone. This compound is produced by reacting 4(3H)-quinazolinone with fluorinated 4-(2-chloroethoxy)biphenyl, resulting in a substance that exhibits higher analgesic activity and lower acute toxicity compared to traditional pain relievers like aminophenazone, ibuprofen, acetylsalicylic acid, and paracetamol.

Career Highlights

Bohumila has worked with prominent companies in the pharmaceutical industry, including Spofa United Pharmaceutical Works and Spofa Spojene Podniky Pro Zdravotnickou. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Throughout his career, Bohumila has collaborated with several professionals, including Jaroslava Grimova and Miroslav Kuchar. These partnerships have enhanced his research and development efforts in the pharmaceutical field.

Conclusion

Bohumila Brunova's contributions to pharmaceutical chemistry through his innovative patents demonstrate his commitment to advancing medical science. His work continues to impact the development of effective therapeutic agents.